Literature DB >> 16971887

National, state, and urban area vaccination coverage among children aged 19-35 months--United States, 2005.

.   

Abstract

The National Immunization Survey (NIS) provides vaccination coverage estimates among children aged 19-35 months for each of the 50 states and selected urban areas. Findings from the 2005 NIS include nationwide increases in coverage with >/=3 and >/=4 doses of pneumococcal conjugate vaccine (PCV) and continued high levels of coverage for the other recommended vaccines and vaccine series. In addition, no racial/ethnic disparities in coverage estimates were observed in the 4:3:1:3:3:1 vaccine series, the recommended series for children aged 19-35 months that includes DTP/DT/DTaP; poliovirus vaccine; measles, mumps, and rubella vaccine (MMR); Haemophilus influenzae type b vaccine; hepatitis B vaccine; and varicella vaccine. An important accomplishment indicated by the 2005 NIS data is the achievement of <50% coverage for the full series of PCV (>/=4 doses) and <80% coverage for >/=3 doses within 5 years after being added to the U.S.-recommended childhood immunization schedule in 2000. This occurred despite shortages of this vaccine during 2001-2004, which might have affected accessibility to PCV.

Entities:  

Mesh:

Year:  2006        PMID: 16971887

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  20 in total

1.  Improving the quality of immunization delivery to an at-risk population: a comprehensive approach.

Authors:  Linda Y Fu; Mark Weissman; Rosie McLaren; Cherie Thomas; Jacquelyn Campbell; Jacob Mbafor; Urvi Doshi; Denice Cora-Bramble
Journal:  Pediatrics       Date:  2012-01-09       Impact factor: 7.124

2.  Control of varicella disease, version 2.0.

Authors:  David W Kimberlin
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

Review 3.  Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data.

Authors:  Frank Destefano; Dina Pfeifer; Hanna Nohynek
Journal:  Bull World Health Organ       Date:  2008-05       Impact factor: 9.408

4.  Protecting the public's health: critical functions of the Section 317 Immunization Program-a report of the National Vaccine Advisory Committee.

Authors: 
Journal:  Public Health Rep       Date:  2013 Mar-Apr       Impact factor: 2.792

5.  To give or not to give: Approaches to early childhood immunization delivery in Oregon rural primary care practices.

Authors:  Lyle J Fagnan; Scott A Shipman; James A Gaudino; Jo Mahler; Andrew L Sussman; Jennifer Holub
Journal:  J Rural Health       Date:  2011-01-11       Impact factor: 4.333

6.  Vaccine knowledge and practices of primary care providers of exempt vs. vaccinated children.

Authors:  Daniel A Salmon; William K Y Pan; Saad B Omer; Ann Marie Navar; Walter Orenstein; Edgar K Marcuse; James Taylor; M Patricia deHart; Shannon Stokley; Terrell Carter; Neal A Halsey
Journal:  Hum Vaccin       Date:  2008-02-19

7.  Effectiveness of a community coalition for improving child vaccination rates in New York City.

Authors:  Sally E Findley; Matilde Irigoyen; Martha Sanchez; Melissa S Stockwell; Miriam Mejia; Letty Guzman; Richard Ferreira; Oscar Pena; Shaofu Chen; Raquel Andres-Martinez
Journal:  Am J Public Health       Date:  2008-09-17       Impact factor: 9.308

Review 8.  Impact of varicella vaccine on varicella-zoster virus dynamics.

Authors:  D Scott Schmid; Aisha O Jumaan
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

9.  Risk of invasive pneumococcal disease varies by neighbourhood characteristics: implications for prevention policies.

Authors:  K A Feemster; Y Li; A R Localio; J Shults; P Edelstein; E Lautenbach; T Smith; J P Metlay
Journal:  Epidemiol Infect       Date:  2012-10-31       Impact factor: 2.451

Review 10.  Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children.

Authors:  Matt Wasserman; Ruth Chapman; Rotem Lapidot; Kelly Sutton; Desmond Dillon-Murphy; Shreeya Patel; Erica Chilson; Vincenza Snow; Raymond Farkouh; Stephen Pelton
Journal:  Emerg Infect Dis       Date:  2021       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.